The FDA’s Vaccines and Related Biological Products Advisory Committee will meet virtually to review the vaccine trial data and discuss emergency use authorization for the companies’ coronavirus vaccine candidate.
Advertisement
The email address for your subscription is [email protected]Manage Email Preferences or Unsubscribe
New York Post 1211 Avenue of the Americas New York, NY 10036 USA
© Copyright 2020 NYP Holdings, Inc. All rights reservedPrivacy | Terms of Use | Your Ad Choices